NCT00381264View on ClinicalTrials.gov

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Multiple Sclerosis
Interventions
DRUG

Cesamet™ (nabilone)

Trial Locations (4)

33021

Sunrise Clinical Research, Inc., Hollywood

33180

South Florida Medical Research, Aventura

33407

Lazlo Mate, MD, West Palm Beach

34108

Naples Anesthesia and Pain Associates, Naples

Sponsors
All Listed Sponsors
lead

NEMA Research, Inc.

INDUSTRY

NCT00381264 - Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis | Biotech Hunter | Biotech Hunter